Upcoming Events More events are coming soon. Past Events American Glaucoma Society (AGS) Feb 27 - Mar 1, 2020 Washington, DC A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG) Supporting Materials Graybug Poster Presentation Feb 28, 2020 3.2 MB Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Presentations and Publications Source PUBLICATION | 2020 Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles, Nature Communications Read More Source POSTER | 2020 A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG) (Hoang 2020 – AGS) Read More 3.2 MB Source POSTER | 2019 An Injectable Formulation of a Beta-Adrenergic Antagonist Prodrug for Sustained Reduction of Intraocular Pressure (IOP) (Hoang 2019 – ARVO) Read More 234.1 KB Source Poster | 2018 Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD) (Yu 2018 – ARVO) Read more 844.1 KB Source POSTER | 2017 Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing (Yang 2017 – ARVO) Read More 361.1 KB
American Glaucoma Society (AGS) Feb 27 - Mar 1, 2020 Washington, DC A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG) Supporting Materials Graybug Poster Presentation Feb 28, 2020 3.2 MB
Source PUBLICATION | 2020 Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles, Nature Communications Read More
Source POSTER | 2020 A Novel Injectable Intravitreal (IVT) Depot Formulation of a Beta-Adrenergic Prodrug as a Potential Sustained-Delivery Treatment in Primary Open Angle Glaucoma (POAG) (Hoang 2020 – AGS) Read More 3.2 MB
Source POSTER | 2019 An Injectable Formulation of a Beta-Adrenergic Antagonist Prodrug for Sustained Reduction of Intraocular Pressure (IOP) (Hoang 2019 – ARVO) Read More 234.1 KB
Source Poster | 2018 Sunitinib-Loaded Injectable Polymer Depot Formulation for Potential Once per Year Treatment of Neovascular Age-related Macular Degeneration (wet AMD) (Yu 2018 – ARVO) Read more 844.1 KB
Source POSTER | 2017 Modifications of Sunitinib-Loaded GB-102 Microparticles that Lengthen Drug Release: 9-Months Ocular Tolerability and PK in Rabbit Following IVT Dosing (Yang 2017 – ARVO) Read More 361.1 KB
